Program Description: 

This presentation will describe the risk factors, clinical presentation and management of preeclampsia.  Emerging prevention and treatment strategies as well as the subsequent maternal health considerations will be highlighted.
 

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Please note: The course fee is $10.00 in addition to a $2.50 processing fee which is assessed for all electronic registrations.
 
More information and online registration:  http://academy.isth.org/isth/ 
 
 
This course is being supported by Instrumentation Laboratory
Target audience: 
  • Basic and clinical scientists in the fields of thrombosis and haemostasis, obstetric haemostasis and pre-eclampsia 
  • Students, researchers and clinicians interested in obstetric haemostasis
Learning objectives: 

At the conclusion of this activity, I will be able to:

  • Detailed understanding of pre-eclampsia as a diverse syndrome and the haemostatic mechanisms involved in its pathogenesis.
  • Update knowledge of the mechanisms and importance of disordered haemostasis in pre-eclampsia and the potential therapeutic implications.
Faculty & credentials: 
Planning Committee:
Geoffrey Barnes, MD
Chris Ward, PhD
Stephen Watson, PhD
Yukio Ozaki
 
Speakers:

Chris Gardiner "Basic pathophysiology of preeclampsia"

Michael Paidas "Clinical aspects"

 
Moderator:  

Rezan Kadir

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  
 

Name

Company

Role

Geoffrey Barnes, MDPortolaConsulting
 Blue Cross Blue Shield of MichiganResearch
 BMS/PfizerResearch
Chris Ward, PhDBayerSpeaker
 Boehringer-IngelheimSpeaker, Advisory Board
 BMS/PfizerSpeaker, Advisory Board
   
Yukio OzakiThe Sysmex CorporationAdvisory Board
Michael PaidasRevo BiologicsPI

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Contact

Name: 
Lacey Schmeidler, MA
Phone number: 
+1 (919) 929-3807
Email: 
lacey_schmeidler@isth.org
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.